Bishal Gyawali, associate professor at Queen’s University, shared a post on LinkedIn:
” In this new paper just published in JCO Oncology Practice, I encourage the oncology community to ask whether some of the new “innovations “ in cancer drug development that supposedly offer more “convenience” to patients are worth the astronomical difference in prices.
Click here for more.”
Title: Cost of Convenience in Cancer Care
Author: Bishal Gyawali
More posts featuring Bishal Gyawali.